A high polymerized grass pollen extract is efficacious and safe in a randomized double-blind, placebo-controlled study using a novel up-dosing cluster-protocol

Recommendations for the standardization of clinical outcomes used in allergen immunotherapy trials for allergic rhinoconjunctivitis: an EAACI Position Paper

(2014) O. Pfaar et al.   ALLERGY

Comparability of subcutaneous and sublingual immunotherapy outcomes in allergic rhinitis clinical trials

(2012) Moises A. Calderon et al.   Current Opinion in Allergy and Clinical Immunology

Klinische Parameter zur Beurteilung der Wirksamkeit einer spezifischen Immuntherapie bei polleninduzierter Rhinitis allergica. Bestimmung von “well days” als ergänzendes Konzept

(2011) S. Vorwalder et al.   ALLERGOLOGIE

A randomized placebo-controlled trial of rush preseasonal depigmented polymerized grass pollen immunotherapy*

(2011) O. Pfaar et al.   ALLERGY

Mechanisms of immunotherapy to aeroallergens

(2011) M. H. Shamji et al.   CLINICAL AND EXPERIMENTAL ALLERGY

Serum Immunologic Markers for Monitoring Allergen-Specific Immunotherapy

(2011) Mohamed H. Shamji et al.   IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA

Allergen-Specific Immunotherapy: Which Outcome Measures are Useful in Monitoring Clinical Trials?

(2011) O. Pfaar et al.   IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA

Immunotherapy with depigmented-polymerized mixed tree pollen extract: a clinical trial and responder analysis

(2010) O. Pfaar et al.   ALLERGY

Cluster protocols in SCIT: enough evidence for practical use?

(2010) Oliver Pfaar et al.   Current Opinion in Allergy and Clinical Immunology

The problem of placebo-controlled trials allowing rescue medication: how to assess efficacy in rhinosinusitis and allergic rhinoconjunctivitis when both groups receive active rescue treatment

(2009) Julia Vent et al.   Current Opinion in Allergy and Clinical Immunology

Safety aspects of Cluster immunotherapy with semi-depot allergen extracts in seasonal allergic rhinoconjunctivitis

(2009) Oliver Pfaar et al.   EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY

Safety of Two Cluster Schedules for Subcutaneous Immunotherapy in Allergic Rhinitis or Asthma Patients Sensitized to Inhalant Allergens

(2009) O. Pfaar et al.   INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY

Safety and efficacy in children of an SQ-standardized grass allergen tablet for sublingual immunotherapy

(2009) Albrecht Bufe et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Allergic Rhinitis and its Impact on Asthma (ARIA) 2008*

(2008) J. Bousquet et al.   ALLERGY

Cluster immunotherapy with a glutaraldehyde-modified mixture of grasses results in an improvement in specific nasal provocation tests in less than 2.5 months of treatment

(2008) J. Subiza et al.   CLINICAL AND EXPERIMENTAL ALLERGY

Comparative Study of Cluster and Conventional Immunotherapy Schedules with Dermatophagoides pteronyssinus in the Treatment of Persistent Allergic Rhinitis

(2008) Luo Zhang et al.   INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY

Safety and Immunogenicity of a Cluster Specific Immunotherapy in Children with Bronchial Asthma and Mite Allergy

(2008) R. Schubert et al.   INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY